Patents by Inventor Manuel B. Sainz

Manuel B. Sainz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8481319
    Abstract: A method for introducing a nucleic acid sequence into the genome of a plant cell and regenerating a transformed plant therefrom, including culturing the plant cell on at least one plant transformation media, the at least one plant transformation media comprising an effective amount of a compound or compounds which may modulate oxidative burst, such as melatonin, 6-hydroxy melatonin (a melatonin analog), N-t-butyl hydroxylamine (NtBH), thiamazole, 1,3 dimethylthiourea, Resveratrol, epicatechin, NADPH, or NADH.
    Type: Grant
    Filed: May 25, 2010
    Date of Patent: July 9, 2013
    Assignee: Syngenta Partcipations AG
    Inventors: Yinghui Dan, Manuel B. Sainz, Heng Zhong, Liang Shi
  • Publication number: 20100325754
    Abstract: A method for introducing a nucleic acid sequence into the genome of a plant cell and regenerating a transformed plant therefrom, including culturing the plant cell on at least one plant transformation media, the at least one plant transformation media comprising an effective amount of a compound or compounds which may modulate oxidative burst, such as melatonin, 6-hydroxy melatonin (a melatonin analog), N-t-butyl hydroxylamine (NtBH), thiamazole, 1,3 dimethylthiourea, Resveratrol, epicatechin, NADPH, or NADH.
    Type: Application
    Filed: May 25, 2010
    Publication date: December 23, 2010
    Inventors: Yinghui Dan, Manuel B. Sainz, Heng Zhong, Liang Shi
  • Patent number: 7098378
    Abstract: The present invention pertains to transgenic plants comprising nucleic acid molecules comprising nucleotide sequences that encode RAR1 proteins involved in disease resistance, and the RAR1 polypeptides. The invention particularly relates to methods of altering the expressing nucleic acid molecules encoding RAR1 proteins in transgenic plants to alter the level disease resistance, and to transgenic plants, progeny and seed therefrom, having altered enhanced disease resistance. The invention further relates to methods of enhancing expression of R resistance genes, disease resistance signal transduction genes, genes involved in mediating disease resistance or involved in the synthesis of molecules mediating disease resistance. The invention also relates to methods of regulating the expression of other coding sequences of interest by increasing the expression of the nucleic acid molecules of the invention.
    Type: Grant
    Filed: December 14, 2004
    Date of Patent: August 29, 2006
    Assignee: Syngenta Participations AG
    Inventors: Manuel B. Sainz, John Salmeron
  • Patent number: 6956115
    Abstract: The present invention pertains to isolated nucleic acid molecules comprising nucleotide sequences isolated from Oryza sativa that encode RARI proteins involved in disease resistance, and recombinant vectors comprising said nucleotide sequences.
    Type: Grant
    Filed: November 27, 2002
    Date of Patent: October 18, 2005
    Assignee: Syngenta Participations AG
    Inventors: Manuel B. Sainz, John Salmeron
  • Publication number: 20040219675
    Abstract: The present invention encompasses nucleic acid molecules isolated from Oryza sativa that encode proteins for conferring abiotic stress tolerance, enhanced yield, disease resistance, or altered nutritional composition in plants. The invention further relates to expression of these molecules in microorganisms and transgenic plants for altering these characteristics of the organism.
    Type: Application
    Filed: April 5, 2004
    Publication date: November 4, 2004
    Inventors: Manuel B Sainz, John Salmeron, Laura Weislo
  • Publication number: 20030140375
    Abstract: The present invention pertains to nucleic acid molecules isolated from Oryza sativa comprising nucleotide sequences that encode RAR1 proteins involved in disease resistance, and the RAR1 polypeptides. The invention particularly relates to methods of altering the expressing nucleic acid molecules encoding RAR1 proteins in transgenic plants to alter the level disease resistance, and to transgenic plants, progeny and seed therefrom, having altered enhanced disease resistance. The invention further relates to methods of enhancing expression of R resistance genes, disease resistance signal transduction genes, genes involved in mediating disease resistance or involved in the synthesis of molecules mediating disease resistance. The invention also relates to methods of regulating the expression of other coding sequences of interest by increasing the expression of the nucleic acid molecules of the invention.
    Type: Application
    Filed: November 27, 2002
    Publication date: July 24, 2003
    Inventors: Manuel B. Sainz, John Salmeron